SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth
What this study shows
mTORC1 activates SREBP to drive lipogenesis supporting Akt-dependent cell growth.
At a glance
| Evidence type | M Molecular — cells, biochemistry, structure Marked M because it is molecular or in-vitro work (model: Mammalian cells) rather than a whole-organism health-outcome study. That is often exactly where causal biology gets established -- the code says which system the finding was shown in, and nothing about how good the work is. |
| Study type | 5 - Mechanistic / In Vitro |
| Model system | Mammalian cells |
| Journal | Cell metabolism |
| Year | 2008 |
| Peer reviewed | Yes |
| Record last updated | 2026-10-01 |
| Source | DOI 10.1016/j.cmet.2008.07.007 · PMID 18762023 · Free full text (PMC2593919) |
Extracted findings
These fields were extracted from the paper with AI assistance and have not been checked against the source. Read them as a pointer into the paper, not as curated claims; where they disagree with the curated summary above, the curated summary stands.
| Intervention | Genetic/pharmacologic (mTORC1/SREBP) |
| Target | mTORC1 / SREBP / Akt |
| Model | Mammalian cells |
| Effect | SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth (lipogenesis) |
In the Atlas
Related topics
Links in the pathway map
More studies on this topic
- Activation of a metabolic gene regulatory network downstream of mTOR complex 1 (2010)
- Hepatic mTORC2 activates glycolysis and lipogenesis through Akt, glucokinase, and SREBP1c (2012)
- Sterol regulatory element-binding proteins are essential for the metabolic programming of effector T cells and adaptive immunity (2013)
- mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway (2011)
Was this page useful?
Thank you. Your answer was counted anonymously.